IHH Healthcare has reported 4QFY2025 earnings of RM528 million, a decrease of 28% y-o-y, bringing full-year earnings to RM2.1 billion, down 21%.
While the operator of hospitals and clinics saw stronger growth especially in Malaysia and India, it suffered unfavourable currency translation effects due to a stronger ringgit, its reporting currency.
If measured on a constant currency basis, the healthcare company's FY2025 earnings would be down 5%.
Despite the lower bottom line, IHH plans to pay a higher final dividend of 10.5 sen per share, versus 10 sen per share paid in FY2024.
“We are delighted by our Q4 and FY2025 results which showcased strong execution particularly in Malaysia and India. Early wins on our multi-year transformation allows us to reward shareholders with a higher dividend of 10.5 sen for the year as we continue to be the largest multinational private healthcare operator outside the US," says group CEO Dr Prem Kumar Nair.
"Looking ahead, we are doubling down on people development and technology-powered productivity," he adds.
See also: OUE slightly trims net loss to $279.1 mil; maintains final dividend at 1 cent per share
This year, IHH expects a stronger contribution from its Singapore operations as Mount Elizabeth Orchard, its flagship hospital here ramps up in the second half after a multi-year refurbishment, during which capacity was curbed.
In Malaysia, the company expects further growth in its daycare volumes.
In India, where IHH has completed its acquisition of Fortis after a long-drawn legal tussle, it expects to enjoy greater flexibility to explore future growth.
See also: Nordic Group reports higher earnings of $19.0 mil for FY2025, up 9% y-o-y
The company, which generated 9% ROE for FY2025, is targeting to achieve double-digit ROE by 2028.
IHH Healthcare's Singapore quoted shares closed at $2.92 on Feb 27, down 0.68% for the day but up 35.81% in the past one year.
